MDMB-ICA

The following information was compiled in November 2023 and is subject to change as new research is conducted and as new information becomes available:

Description: MDMB-ICA is a synthetic cannabinoid precursor that can be used to produce MDMB-PICA and other structurally related synthetic cannabinoids. To date, MDMB-ICA has appeared alongside only MDMB-PICA in drug materials and/or toxicology samples tested by our laboratory in the United States. Synthetic cannabinoid precursors (e.g., MDMB-INACA, ADB-INACA, MDMB-5’Br-INACA) began appearing after the implementation of a national class-wide synthetic cannabinoid scheduling action imposed by China in July 2021.

Sample Source: Northern Tier Research (Pennsylvania)

Sample Appearance: Toxicology specimens (extracts)

Pharmacology: The activity and potency of MDMB-ICA are unknown; however, based on structurally similar synthetic cannabinoid precursors, MDMB-ICA is expected to be inactive or have low potency.

Toxicology: MDMB-ICA has been detected in six toxicology samples at the CFSRE.

Drug Materials: MDMB-ICA has not been identified in drug materials to date at the CFSRE.

Demographics / Geographics: Samples originated from the state of Pennsylvania.

Legal Status: MDMB-ICA is not explicitly scheduled in the United States.

Class:

Cannabinoid

Appearance:

Blood, urine

Formula:

C16H20N2O3

MW:

288.3

[M+]:

288

[M+H]+:

289.1547

IUPAC:

methyl 2-(1H-indole-3-carbonylamino)-3,3-dimethyl-butanoate

Report Date:

November 28, 2023